Is High-Grade Dysplasia or Carcinoma in Situ Cancer?
At a Glance
In oral leukoplakia, high-grade dysplasia is a high-risk precancerous change, while carcinoma in situ is generally non-invasive, Stage 0 cancer. Neither is invasive cancer, but a small biopsy can miss an invasive area, so prompt specialist care and close follow-up are important.
The Short Answer
If your pathology report shows high-grade dysplasia (also called severe dysplasia) or carcinoma in situ, it means that the cells in your oral leukoplakia are markedly abnormal.
- High-grade dysplasia is a high-risk precancerous change.
- Carcinoma in situ is generally classified as non-invasive cancer (often referred to as Stage 0).
Neither of these is the same as invasive cancer. However, both require prompt specialist management because they carry a substantially increased, though variable, risk of progressing, and a small biopsy can sometimes miss invasive areas nearby [1][2][3].
Understanding the Terminology
Leukoplakia is a clinical description for a white patch in the mouth. Dysplasia and carcinoma in situ are microscopic diagnoses—they describe exactly what the pathologist sees when looking at the cells under a microscope [4].
To understand your diagnosis, it helps to picture the lining of your mouth like layers of a cake. The top layer (the epithelium) sits on a sturdy boundary called the basement membrane.
- High-Grade (Severe) Dysplasia: The cells in the top layer look very disorganized and abnormal, but they remain entirely above the basement membrane. This is a precancer [1].
- Carcinoma in Situ (CIS): “In situ” means “in its original place.” The cells look virtually identical to cancer cells and the changes span the entire thickness of the top layer, but they are still completely contained above the basement membrane [2]. It is considered non-invasive cancer [3].
- Invasive Squamous Cell Carcinoma: This is true invasive cancer. The abnormal cells have broken through the basement membrane and invaded the deeper tissues below [5].
Can It Spread?
If a lesion is truly confined above the basement membrane, as in pure dysplasia or carcinoma in situ, it cannot spread (metastasize) to your lymph nodes or other parts of your body [5][6]. However, if an invasive area was not sampled during your biopsy, that unsampled area could carry different risks.
Why Biopsies Don’t Always Tell the Whole Story
When a doctor biopsies oral leukoplakia, they usually take a small sample of the most suspicious-looking area (an incisional biopsy). While this is the appropriate first step, a small sample might not capture the entire picture.
Research shows that an incisional biopsy might show high-grade dysplasia or carcinoma in situ, but a different, unsampled part of the same leukoplakia patch might already contain invasive cancer [7][8]. Because of this “under-sampling” risk, specialists treat these diagnoses very seriously [9].
Standard Next Steps and Management
Because high-grade dysplasia and carcinoma in situ are high-risk findings, prompt management by a specialist—such as an oral and maxillofacial surgeon, an oral medicine specialist, or an Ear, Nose, and Throat (ENT)/head-and-neck surgeon—is important [10].
- Pathology Review: Having your biopsy slides reviewed by an expert oral or head-and-neck pathologist helps confirm the exact grade of the cells and carefully assess for any signs of invasion [11].
- Surgical Excision: Complete surgical removal of the lesion is often recommended or considered [11][12]. The approach depends on the lesion’s site, its size, and how surgery might affect your speech, chewing, and appearance. Removing the tissue treats the lesion and allows the pathologist to examine the entire area to check for unsampled invasion [9].
- Checking Margins: If surgery is performed, the pathologist checks the edges of the removed tissue (the margins). Clear margins lower the chance of residual abnormal tissue being left behind, but they do not eliminate the risk of recurrence [13]. Because of “field cancerization,” the surrounding mouth lining may still be at risk for new lesions [14].
- Close Surveillance: You will need long-term follow-up. Periodic exams are essential to monitor your mouth for any returning or new lesions [15][12]. Quitting tobacco and limiting alcohol can help support your overall oral health and lower future risks, though these lifestyle changes do not replace the need for active treatment and surveillance.
Symptoms to Watch For
While waiting for your specialist appointment or during long-term surveillance, contact your doctor promptly if you develop any of the following symptoms:
- Persistent ulceration or bleeding
- Increasing pain or new numbness
- A rapidly growing, thickening, or changing patch
- A lump in your neck
- Difficulty swallowing or speaking
These symptoms do not automatically mean you have invasive cancer, but they warrant prompt medical evaluation [16][5].
Common questions in this guide
Does high-grade dysplasia in oral leukoplakia mean I have invasive cancer?
Is carcinoma in situ the same as oral cancer?
Why might my biopsy need expert review or more tissue removed?
What treatment is recommended for high-grade dysplasia or carcinoma in situ?
What do clear margins mean after oral leukoplakia surgery?
Which changes should I report while waiting for care or during surveillance?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Should my biopsy slides be reviewed by an expert oral or head-and-neck pathologist?
Treatment options
Would complete surgical removal of the lesion be recommended for me?
Follow-up care
How often would periodic exams be needed to check my mouth?
Related questions
Show more
Get notified when new evidence is published on oral mucosa leukoplakia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Management of a carcinoma in situ of the tongue margin, using a Nd:YAG laser, cross-linked hyaluronic acid (xHyA) gel and a porcine pericardium resorbable membrane: a case report.
Iaria R, Giovannacci I, Meleti M, et al.
BMC oral health 2025; (25(1)):378 doi:10.1186/s12903-025-05701-3.
PMID: 40082873 - 2
Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges.
Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK
Periodontology 2000 2019; (80(1)):126-147 doi:10.1111/prd.12259.
PMID: 31090138 - 3
The Malignant Transformation Rate of Oral Carcinoma In Situ.
Meci A, Goyal N, Goldenberg D
The Laryngoscope 2026; (136(1)):213-217 doi:10.1002/lary.70025.
PMID: 40781890 - 4
Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.
Novack R, Zhang L, Hoang LN, et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023; (36(7)):100153 doi:10.1016/j.modpat.2023.100153.
PMID: 36906072 - 5
Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.
Yasothkumar D, Ramani P, Ramasubramanian A
Head and neck pathology 2025; (19(1)):96 doi:10.1007/s12105-025-01833-8.
PMID: 40758174 - 6
Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis.
Bugshan A, Farooq I
F1000Research 2020; (9()):229 doi:10.12688/f1000research.22941.1.
PMID: 32399208 - 7
Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.
Maloney B, Jung MS, Byrne J, et al.
Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.
PMID: 42020233 - 8
When Clinical Suspicion Outweighs a Negative Biopsy: Early Tongue Squamous Cell Carcinoma Diagnosed After Persistent Oral Leukoplakia.
Reboredo P, Nogueira P, Boer N, et al.
Cureus 2026; (18(8)):e114040 doi:10.7759/cureus.114040.
PMID: 42701507 - 9
Intraepithelial CD163+ macrophages in tongue leukoplakia biopsy: A promising tool for cancer screening.
Shigeoka M, Koma YI, Kodama T, et al.
Oral diseases 2020; (26(3)):527-536 doi:10.1111/odi.13269.
PMID: 31886947 - 10
Clinical features and presentation of oral potentially malignant disorders.
Warnakulasuriya S
Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):582-590 doi:10.1016/j.oooo.2018.03.011.
PMID: 29673799 - 11
Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S
Clinical oral investigations 2020; (24(12)):4563-4569 doi:10.1007/s00784-020-03322-4.
PMID: 32436158 - 12
Surgical treatment compared with "wait and see" in patients affected by oral leukoplakia to prevent oral cancer: Preliminary data from a multicenter randomized controlled trial.
Lombardi N, Arduino PG, Lampiano M, et al.
Oral diseases 2025; (31(3)):807-814 doi:10.1111/odi.15058.
PMID: 38938085 - 13
Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis.
Bhattarai BP, Singh AK, Singh RP, et al.
Journal of dental research 2024; (103(11)):1066-1075 doi:10.1177/00220345241266519.
PMID: 39290142 - 14
Surgical protocols for oral leukoplakia and precancerous lesions across three different anatomic sites.
Pedroso CM, do Santos ES, Alves FA, et al.
Oral diseases 2025; (31(1)):89-98 doi:10.1111/odi.15098.
PMID: 39155483 - 15
Oral leukoplakia and oral cavity squamous cell carcinoma.
Bewley AF, Farwell DG
Clinics in dermatology 2017; (35(5)):461-467 doi:10.1016/j.clindermatol.2017.06.008.
PMID: 28916027 - 16
Evaluation of Clinical Outcomes and Recurrence After Surgical Excision of Oral Leukoplakia: A Prospective Cohort Study.
Talreja L, Goyal R, Yadav D, et al.
Cureus 2024; (16(10)):e71593 doi:10.7759/cureus.71593.
PMID: 39552995
This page is for informational purposes only and does not constitute medical advice. Your oral pathologist and treating specialist should interpret your biopsy, assess whether it represents the full lesion, and recommend care for your situation.